“…An improper response to DNA damage is a cancer hallmark and contributes to tumorigenesis and chemo/radiotherapeutic resistance. ASPM overexpression has been observed in various cancers ( Xu et al., 2019 , 2020 ; Zhou et al., 2020 ; Alsiary et al., 2014 ; Bruning-Richardson et al., 2011 ; Saleh et al., 2020 ; Xie et al., 2017 ; Tian and Wang, 2020 ; Timaner and Shaked, 2020 ; Hsu et al., 2019 ; Wang et al., 2013 ; Tang et al., 2019 ; Lin et al., 2008 ; Yuan et al., 2020 ; Wu et al., 2021 ) and thus might serve as a prognostic marker in various contexts. ASPM is a positive regulator of the canonical Wnt/β-catenin signaling ( Major et al., 2008 ; Hsu et al., 2019 ) and thus promotes cancer stemness and progression in prostate cancer ( Pai et al., 2019 ) and hepatocellular carcinoma ( Liao et al., 2020 ).…”